Neuropacs Announces the Publication of a New Study Comparing the First-of-Its-Kind FDA De Novo–Classified Imaging Biomarker for Parkinson’s Disease With CSF Alpha-Synuclein Seed Amplification Assay (Business wire)
UF startup Neuropacs announced new research highlighting its AI-powered Parkinson’s diagnostic technology, which recently received FDA clearance for clinical use.
Gut Bacteria Could Unlock Prevention of Parkinson’s, Alzheimer’s Disease, UF/IFAS Study Suggests
UF researchers published a study that suggests specific “good” gut bacteria could contribute to preventing Parkinson’s and Alzheimer’s Disease.